falko-gunter

REVERSED

1600 Biotechnology and Organic Chemistry
1657 Ex Parte Mishra 11/494,166 McCOLLUM 112(1) KNOBBE MARTENS OLSON & BEAR LLP EXAMINER SAUCIER, SANDRA E

2400 Networking, Mulitplexing, Cable, and Security
2443 Ex Parte Gorthy et al 09/942,834 BARRY 103(a) IBM CORP. (WIP) c/o WALDER INTELLECTUAL PROPERTY LAW, P.C. EXAMINER COONEY, ADAM A

2800 Semiconductors, Electrical and Optical Systems and Components
2858 Ex Parte Nair 11/582,069 STEPHENS 103(a) Delphi Technologies, Inc. EXAMINER NATALINI, JEFF WILLIAM

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3643 Ex Parte Song 11/716,256 McCOLLUM 102(b)/103(a) Bay Area Technolgy Law Group PC EXAMINER HAYES, KRISTEN C

3700 Mechanical Engineering, Manufacturing, and Products & Design
3721 Ex Parte Hueil et al 11/711,979 CALVE 103(a) K&L Gates LLP EXAMINER CHUKWURAH, NATHANIEL C

3731 Ex Parte Tischler et al 11/753,829 FREDMAN 103(a) VIDAS, ARRETT & STEINKRAUS, P.A. EXAMINER MILES, JONATHAN WADE

3732 Ex Parte Wyllie et al 11/536,724 COCKS 103(a) 3M INNOVATIVE PROPERTIES COMPANY EXAMINER SINGH, SUNIL K

3733 Ex Parte Jacobs et al 10/746,749 SCHEINER 102(b)/103(a) Maginot, Moore & Beck LLP EXAMINER HOFFMAN, MARY C

3739 Ex Parte MULIER et al 11/966,769 GRIMES 102(b)/103(a) Medtronic, Inc. (CRDM) EXAMINER COHEN, LEE S

AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
1642 Ex Parte Chiang et al 11/155,288 MILLS 112(1) 112(1) Davis Wright Tremaine LLP/MannKind Corporation EXAMINER HALVORSON, MARK

(1) [E]xamples are not necessary to support the adequacy of a written description[;] (2) the written description standard may be met . . . even where actual reduction to practice of an invention is absent; and (3) there is no per se rule that an adequate written description of an invention that involves a biological macromolecule must contain a recitation of known structure. Falko-Gunter Falkner v. Inglis, 448 F.3d 1357, 1366 (Fed. Cir. 2006).

2600 Communications
2627 Ex Parte Che et al 11/542,354 SIU 102(b) 102(b) HITACHI C/O WAGNER BLECHER LLP EXAMINER WONG, KIN C

3700 Mechanical Engineering, Manufacturing, and Products & Design
3779 Ex Parte Whitman 10/127,310 FREDMAN 112(1)/102(b)/103(a) Tyco Healthcare Group LP d/b/a Covidien EXAMINER LEUBECKER, JOHN P
AFFIRMED

1600 Biotechnology and Organic Chemistry
1651 Ex Parte De Simone 11/576,130 ADAMS 103(a) NIXON & VANDERHYE, PC EXAMINER GOUGH, TIFFANY MAUREEN

2100 Computer Architecture and Software
2171 Ex Parte Koivisto et al 11/007,028 DIXON 103(a) Nokia Corporation and Alston & Bird LLP c/o Alston & Bird LLP EXAMINER SALOMON, PHENUEL S

2174 Ex Parte Lyudovyk et al 11/374,444 WINSOR 102(e)/103(a) HAMILTON & TERRILE, LLP EXAMINER JOHNSON, GRANT D

2400 Networking, Mulitplexing, Cable, and Security
2454 Ex Parte Watanabe 10/398,907 RUGGIERO 102(e)/103(a) RADER FISHMAN & GRAUER PLLC EXAMINER LIN, WEN TAI

2600 Communications
2626 Ex Parte Krishnan 10/858,578 MORGAN 103(a) Nokia Corporation and Alston & Bird LLP c/o Alston & Bird LLP EXAMINER SAINT CYR, LEONARD

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3671 Ex Parte Gertner 11/142,599 McCARTHY 103(a) 37 C.F.R. § 41.50(b) 103(a) MEREK, BLACKMON & VOORHEES, LLC EXAMINER MCGOWAN, JAMIE LOUISE

3700 Mechanical Engineering, Manufacturing, and Products & Design
3725 Ex Parte Schutz 10/977,616 CALVE 103(a) LUCAS & MERCANTI, LLP EXAMINER FRANCIS, FAYE

REHEARING

DENIED

2100 Computer Architecture and Software
2111 Ex Parte Watts et al 10/837,106 DIXON 102(e)/102(b)/obviousness-type double patenting TEXAS INSTRUMENTS INCORPORATED EXAMINER AUVE, GLENN ALLEN

DENIED

3900 Central Reexamination Unit (CRU)
2874 Ex Parte 6,868,220 et al PANDUIT CORPORATION Requester and Cross-Appellant v. Patent of ADC TELECOMMUNICATIONS Patent Owner and Respondent 95/000,412 LEBOVITZ 102(b)/103(a)/112(2) MERCHANT & GOULD PC EXAMINER ENGLISH, PETER C original EXAMINER PALMER, PHAN T H